Distribution agreement

RNS Number:4990P
Healthcare Enterprise Group PLC
15 January 2007

15 January 2007

Healthcare Enterprise Group PLC

$4.5 million Ebiox Distribution Agreement



Healthcare Enterprise Group PLC ("HCEG", AIM: HCEG) announces that its wholly
owned subsidiary, Ebiox Limited, has secured an agreement with Sultan
Healthcare, Inc ("Sultan") for the exclusive marketing of the Ebiox range of
disinfection products to the dental sector in UK, continental Europe, Latin
America, South America, Asia and Africa.



The agreement which is for an initial term of five years, requires Sultan to
purchase a minimum US$4.5 million (#2.33 million) of Ebiox products over that
time, including US$625,000 (#325,000) in 2007, US$875,000 (#455,000) in 2008,
and US$1 million (#520,000) in each of the following three years. Sultan has
agreed to meet these minimum purchase levels as a contractual obligation,
subject only to Ebiox's capacity to supply.



Sultan is a leading US based international manufacturer of dental and medical
products which has three distribution centres; Englewood, New Jersey, USA;
Ontario, Canada and Amsterdam, Holland, supporting sales through distribution
partners into 70 countries. Distribution partners are supported by territory
managers in each market worldwide, giving Sultan wide coverage in all dental
markets.



Sultan has also been granted a non exclusive right to sell Ebiox into the
medical supply market.



In addition, as various Ebiox products receive regulatory approval, Sultan will
market the products in North America. This will be the subject of a separate
agreement with Sultan with additional purchase requirements for the North
American market.



Lyndon Gaborit, HCEG Executive Deputy Chairman commented:



"This is a significant step forward in the profitable expansion of the Ebiox
business. Sultan's choice of Ebiox as the best product to satisfy growing demand
in the dental sector for a non alcohol based suite of products, not only in the
USA but also the rest of the world, is testimony to the product's effectiveness
in decontamination and disinfection.  We are delighted with this endorsement of
the Board's strategy for developing the range."



Paul Seid, President of Sultan commented:



"We are pleased to have secured exclusivity to market Ebiox disinfection
products to our dental and medical customers in these territories.  Having
analysed the product we are confident about the growth opportunity this
represents for Sultan from this exciting development of our portfolio. We
believe that the Ebiox technology of non-alcohol disinfection that will remove
biofilm and clean to the molecular level is the greatest improvement on
disinfection efficiency and efficacy  in 25 years. Additionally, the products
have superb compatibility with commonly used dental and medical surfaces and
materials.  The Ebiox technology will certainly add to our leadership position
in infection control worldwide."





Enquiries:



Healthcare Enterprise Group                           + 44 (0)20 7351 7500
Lyndon Gaborit, Executive Deputy Chairman

Sultan Healthcare, Inc   
Paul Seid, President                                  Email: [e-mail]
                                                      [phone]

College Hill                                          [phone]
Adrian Duffield / Corinna Dorward




Notes



Healthcare Enterprise Group PLC



HCEG is a business engaged in medical product distribution, occupational health,
and first aid markets.  These businesses underpin a range of innovative medical
devices. HCEG is listed on the Alternative Investment Market (AIM) of the London
Stock Exchange.

Ebiox

Patented decontamination and disinfectant products that are safe and alcohol
free but substantially more effective than  conventional methods at destroying
embedded microorganisms.  The Ebiox range includes hand hygiene products,
surface disinfectants, products to clean and decontaminate surgical instruments,
and dental cleaning products.

Sultan Healthcare, Inc.



Sultan, founded in 1872, is a leading manufacturer and distributor of Dental
Materials, Infection Control Products, Preventives and Oral Pharmaceuticals.
Sultan's leading brands include GENIE(R) Impression Material, PUREVAC(R)
Evacuation System Cleaner, PROSONIC(R) Ultrasonics, COMFIT(R) Face Masks, ASSURE
(R) Plus Sterilization Pouches, SENSITEMP(R) Temporary Cement, VERSATEMP(R)
Crown and Bridge Material, HYDROCAST(R) Functional Impression Material, TOPEX
Topical Anesthetic, TOPEX Fluorides, TOPEX ProphyPaste and UPGRADE(R) Disposable
Prophy Angles.



Sultan has a robust research and development pipeline of new products such as
the current launches of SILGIMIX(R) Alginate Replacement Material, INSTAFRESHTM
Hand Sanitizer, PUREVAC HgTM Amalgam Separation System, CLEANLETSTM Ultrasonic
Tablets and ZYMEX(R) Super Foaming Enzymatic Spray.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCOKPKKOBKKNDD